GSA Capital Partners’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.22M Buy
2,245,449
+1,279,247
+132% +$692K 0.09% 341
2025
Q1
$634K Buy
966,202
+934,649
+2,962% +$613K 0.06% 633
2024
Q4
$32K Sell
31,553
-314,079
-91% -$319K ﹤0.01% 1546
2024
Q3
$299K Sell
345,632
-587,544
-63% -$508K 0.02% 1213
2024
Q2
$334K Buy
933,176
+568,892
+156% +$204K 0.02% 1210
2024
Q1
$244K Sell
364,284
-711,406
-66% -$477K 0.02% 1319
2023
Q4
$584K Buy
1,075,690
+515,959
+92% +$280K 0.05% 692
2023
Q3
$336K Sell
559,731
-247,223
-31% -$148K 0.03% 1012
2023
Q2
$1.05M Buy
806,954
+587,866
+268% +$764K 0.1% 284
2023
Q1
$386K Buy
219,088
+18,623
+9% +$32.8K 0.04% 872
2022
Q4
$629K Buy
200,465
+185,415
+1,232% +$582K 0.08% 456
2022
Q3
$74K Sell
15,050
-7,735
-34% -$38K 0.01% 1399
2022
Q2
$94K Sell
22,785
-13,193
-37% -$54.4K 0.01% 1230
2022
Q1
$209K Buy
+35,978
New +$209K 0.03% 1152
2021
Q4
Sell
-32,240
Closed -$290K 1757
2021
Q3
$290K Buy
+32,240
New +$290K 0.03% 1043
2020
Q3
Sell
-10,223
Closed -$92K 1371
2020
Q2
$92K Buy
+10,223
New +$92K 0.05% 493
2020
Q1
Sell
-10,189
Closed -$85K 1503
2019
Q4
$85K Buy
+10,189
New +$85K 0.01% 1349
2019
Q2
Sell
-65,031
Closed -$620K 1698
2019
Q1
$620K Sell
65,031
-13,569
-17% -$129K 0.06% 559
2018
Q4
$902K Buy
+78,600
New +$902K 0.1% 257
2018
Q2
Sell
-23,221
Closed -$441K 1904
2018
Q1
$441K Buy
+23,221
New +$441K 0.02% 1132
2015
Q2
Sell
-63,576
Closed -$997K 2162
2015
Q1
$997K Buy
+63,576
New +$997K 0.04% 861
2014
Q2
Sell
-15,249
Closed -$276K 1948
2014
Q1
$276K Buy
+15,249
New +$276K 0.02% 1192